CSIMarket
 


Organogenesis Holdings Inc   (ORGO)
Other Ticker:  
 

Organogenesis Holdings Inc 's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


Return On Assets (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Total Assets Change 23.45 % 28.35 % 36.68 % 50.52 % 50.32 %
Y / Y Net Income Change -98.29 % -57.73 % -99.13 % 179.52 % -39.92 %
Net Income (TTM) in Millions 61 73 85 95 62
Return On Assets (TTM) 13.55 % 17.14 % 21.19 % 25.5 % 18.42 %
Total Ranking # 456 # 376 # 271 # 229 # 329
Total Assets (TTM) in Millions 457 456 436 443 370
Seq. Total Assets Change 0.2 % 4.6 % -1.58 % 19.66 % 4.18 %
Seq. Net Income Change -97.54 % 9950.57 % -99.83 % 311.03 % -39.2 %


Roa Comment
Organogenesis Holdings Inc yielded Return on Asset in III. Quarter below company average, at 13.55 %.

Return on assets decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 79 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from 376 to 456.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 38
Sector # 80
Overall # 455

Return On Assets Statistics
High Average Low
25.5 %
17.84 %
7.43 %
(Dec 31 2021)   (Dec 31 2020)


Financial Statements
Organogenesis Holdings Inc 's Assets $ 457 Millions ORGO's Balance sheet
Organogenesis Holdings Inc 's Income $ 0 Millions Quarterly ORGO's Income Statement
ORGO's Income by Division See ORGO's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
Y / Y Total Assets Change 50.52 % 33.78 % 34.88 % -47.82 % -
Total Assets in Millions 443 294 220 163 313
Y / Y Net Income Change 428.73 % - - - -
Net Income in Millions 95 18 -40 -65 -2
Return On Assets 21.41 % 6.09 % -18.38 % -39.72 % -0.67 %




Roa Comment
In the fiscal year 2021 ROA improved to 21.41 % compare to previous year, due to annual net income growth of 428.73 % to $94.90 millions, while value of Organogenesis Holdings Inc 's overall assets grew just by 50.52 % to $443.26 millions, compare to $443.26 a year before.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ORGO's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for ORGO's Competitors
Roa for Organogenesis Holdings Inc 's Suppliers
Return On Asstes for ORGO's Customers

You may also want to know
ORGO's Roi ORGO's Inventory Turnover Ratio ORGO's Growth Rates ORGO's Dividend Comparisons
ORGO's Profitability Ratios ORGO's Asset Turnover Ratio ORGO's Dividend Growth
ORGO's Roe ORGO's Valuation Ratios ORGO's Financial Strength Ratios ORGO's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA
Oncotelic Therapeutics Inc   35.42 %
Biofrontera Inc   34.40 %
Prophase Labs Inc   32.74 %
Cen Biotech Inc  32.09 %
Dynavax Technologies Corporation  31.51 %
Iteos Therapeutics Inc   31.38 %
Ethema Health Corporation   30.79 %
Harmony Biosciences Holdings inc   30.44 %
Innoviva Inc   29.71 %
Exelixis Inc   29.31 %
Reflect Scientific Inc   29.05 %
Orgenesis Inc   28.76 %
Maravai Lifesciences Holdings Inc   25.27 %
Mettler Toledo International Inc  25.16 %
Selecta Biosciences Inc  24.84 %
Catalyst Pharmaceuticals Inc   24.67 %
Corcept Therapeutics Inc  24.31 %
National Research Corporation  23.92 %
Semler Scientific inc   22.46 %
Shockwave Medical Inc   21.85 %
Vertex Pharmaceuticals Inc  21.83 %
Oramed Pharmaceuticals Inc   21.79 %
Candel Therapeutics Inc   21.17 %
Journey Medical Corporation  21.14 %
Taitron Components Incorporated  20.42 %
Regeneron Pharmaceuticals Inc   20.14 %
Chemed Corporation  20.04 %
Akili Inc   20.04 %
Fulgent Genetics Inc   19.22 %
West Pharmaceutical Services Inc   18.98 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ORTX's Profile

Stock Price

ORTX's Financials

Business Description

Fundamentals

Charts & Quotes

ORTX's News

Suppliers

ORTX's Competitors

Customers & Markets

Economic Indicators

ORTX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071